In honor of Mental Health Awareness Month, join Genomind and Dr. Robert M. Post for a presentation on updates on treatment of bipolar disorders and the excess of childhood onsets in the US.
Dr. Post is Founder and Head, Bipolar Collaborative Network and Professor of Psychiatry at George Washington University School of Medicine. He was formerly Chief, Biological Psychiatry Branch for many of his 36 years at the NIMH, where his research focused on better understanding and treating patients with refractory unipolar and bipolar illness. His group has won major awards from the Society of Biological Psychiatry, APA, ACNP, Anna Monika Foundation, NARSAD, NDMDA, and in 2010 NAMI. Dr. Post is on multiple editorial boards and has published more than 1,000 manuscripts. He is the author of a recent book entitled: “Treatment of Bipolar Illness: A Casebook for Clinicians and Patients” published by Norton in 2008, and editor of the Bipolar Network News (BNN), a quarterly newsletter available online at www.bipolarnews.org. He is currently in private practice doing consultations on patients with difficult-to-treat mood disorders.
In this 1-hour session, Dr. Post will lead a 45-minute presentation on bipolar disorder, then conclude with a 15-minute Q&A session. For those unable to attend, a recording of the event will be sent to all registrants on a later date.
Filmed May 26th, 2021
Are You Ready to Upgrade Your Practice with Genomind?
Genomind’s pharmacogenetic testing is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today!